Analyst Says Not to Chase J.C. Penney’s Citigroup Upgrade
While J.C. Penney has taken some positive steps toward a turnaround, the retail analysts at Sterne Agee are advising their clients that chasing this name is not a good idea.
While J.C. Penney has taken some positive steps toward a turnaround, the retail analysts at Sterne Agee are advising their clients that chasing this name is not a good idea.
The pricier the stock market gets, the more important it is for investors to keep a close eye on what they are paying for stocks. Flashy momentum stocks are great for traders, but investors…
Vornado Realty Trust apparently is looking for any avenue it can to generate more value for its shareholders. The New York-based commercial landlord reportedly is considering a spin-off of its suburban shopping centers as…
ThinkstockWednesday, the makers of the popular smartphone game Candy Crush Saga filed for an initial public offering. Dublin-based King Digital Entertainment plans to offer more than 22 million shares, priced at $21 to $24…
Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late February. Those bucking that trend include BioMarin Pharmaceutical and Medivation.
Shares of Las Vegas-based casino operator Boyd Gaming took off in after-hours trading Monday after a regulatory filing from activist hedge fund Elliott Associates disclosed that it owns 4.99% of Boyd's shares outstanding.
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In a new research report, Cowen highlights upcoming catalysts that could send some of the…
La Jolla Pharmaceutical shares surged after the micro-cap biotech said late Monday that its study for a chronic kidney disease treatment showed a statistically significant improvement.
Due to its greater reach along the U.S. East Coast arising from its recent merger with US Airways, American Airlines said Monday that it has ended its inline agreements with JetBlue Airways. It also…
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events and drugs.
ThinkstockThe amount of global debt swelled to more than $100 trillion last year, according to the Swiss-based Bank for International Settlements (BIS), as governments borrowed to lift their economies out of recession and corporations…
In the wake of recent high-profile data breaches, Visa and MasterCard said Friday that they have formed a new group aimed at improving payment system security. The new group will include banks, retailers and…
Less than three months after its rebirth, American Airlines is on pace for a record annual profit estimated at $3.5 billion putting it ahead of rivals Delta Air Lines and United Continental.
The biotech and specialty pharmaceutical groups got hit hard Thursday for a variety of reasons. The largest of which the analysts at Jefferies believe, is commentary within Washington's new budget proposal regarding tax inversion…
After a rough couple of days for investors in McDermott International, a ray of sunshine Thursday following the announcement that the the engineering and construction specialist for the oil industry won a large contract.
Activist investor Carl Icahn has "not yet begun to fight" according to his latest open letter to the shareholders of eBay. His impetus was an investor survey that showed 55% of respondents support a…
As the Wi-Fi market continues its run to be everywhere and ubiquitous, the top companies providing seamless and scalable delivery for their customers will continue to dominate. These are Oppenheimer's top stocks in the…
Here are the four top names added to the Credit Suisse Top Picks list. Investors with a long-term stock horizon should do very well by adding any or all of them to a diversified…
The Institutional Portfolio team at Oppenheimer has run their screens looking for the stocks that can outperform over the next 30 days. Here are some of the best ideas for March from Oppenheimer.
Morgan Stanley reportedly is considering its options, including a possible outright sale, for its private Swiss private banking business. Other international banks have also offloaded their Swiss operations recently.